The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic chemotherapy (CT) as salvage treatment for locally advanced rectal cancer (LARC) patients (pts) who fail to respond to neoadjuvant chemoradiotherapy (CRT).
 
Francesco Sclafani
No Relationships to Disclose
 
Gina Brown
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Sheela Rao
No Relationships to Disclose
 
Paris P Tekkis
No Relationships to Disclose
 
Diana M. Tait
No Relationships to Disclose
 
Federica Morano
No Relationships to Disclose
 
Chiara Baratelli
No Relationships to Disclose
 
Eleftheria Kalaitzaki
No Relationships to Disclose
 
Shahnawaz Rasheed
No Relationships to Disclose
 
David J. Watkins
No Relationships to Disclose
 
Naureen Starling
No Relationships to Disclose
 
Andrew Wotherspoon
No Relationships to Disclose
 
Ian Chau
Honoraria - Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly; Macrogenics; MSD Oncology; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi